CHENGDU BRIGHT EYE HOSPITAL CO., LTD. Financials Chengdu Bright Eye Hospital Co., Ltd.
Equities
301239
CNE100005GX3
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.84 CNY | -5.24% |
|
-9.63% | -58.33% |
| 05-24 | Chengdu Bright Eye Hospital Co., Ltd. Approves 2023 Profit Distribution Plan | CI |
| 04-24 | Chengdu Bright Eye Hospital Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 10,563 | 12,867 | 5,313 | - | - |
| Enterprise Value (EV) 1 | 10,563 | 12,867 | 5,313 | 5,313 | 5,313 |
| P/E ratio | 441 x | 48 x | 33.4 x | 15 x | 16.1 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 4.73 x | 1.75 x | 1.31 x | 1.27 x |
| EV / Revenue | - | 4.73 x | 1.75 x | 1.31 x | 1.27 x |
| EV / EBITDA | - | 17.8 x | 8.29 x | 6.39 x | - |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | 5.61 x | 1.98 x | 1.71 x | 1.44 x |
| Nbr of stocks (in thousands) | 149,619 | 149,619 | 148,864 | - | - |
| Reference price 2 | 70.60 | 86.00 | 35.69 | 35.69 | 35.69 |
| Announcement Date | 25/04/23 | 23/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 2,718 | 3,044 | 4,044 | 4,173 |
| EBITDA 1 | - | 724.5 | 641 | 832 | - |
| EBIT 1 | - | 386 | 261 | 512.5 | 546 |
| Operating Margin | - | 14.2% | 8.57% | 12.67% | 13.08% |
| Earnings before Tax (EBT) 1 | - | 362.2 | 243 | 489.5 | 526 |
| Net income 1 | 20.57 | 267.9 | 160 | 355.5 | 333 |
| Net margin | - | 9.86% | 5.26% | 8.79% | 7.98% |
| EPS 2 | 0.1600 | 1.790 | 1.070 | 2.375 | 2.220 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 25/04/23 | 23/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 12.2% | 6% | 8.2% | 9% |
| ROA (Net income/ Total Assets) | - | 6.31% | 12.3% | 14.6% | - |
| Assets 1 | - | 4,246 | 1,301 | 2,435 | - |
| Book Value Per Share 2 | - | 15.30 | 18.00 | 20.90 | 24.70 |
| Cash Flow per Share 2 | - | 4.110 | 1.110 | 4.590 | 4.860 |
| Capex 1 | - | 627 | 770 | 535 | - |
| Capex / Sales | - | 23.06% | 25.3% | 13.23% | - |
| Announcement Date | 25/04/23 | 23/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
35.69
CNY
Average target price
107.7
CNY
Spread / Average Target
+201.71%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -58.33% | 732M | |
| -32.87% | 13.37B | |
| +4.15% | 11.75B | |
| -3.60% | 11.57B | |
| +8.66% | 10.85B | |
| +27.20% | 8.55B | |
| -11.44% | 7.24B | |
| +7.99% | 6.84B | |
| +9.12% | 6.5B | |
| +15.49% | 4.39B |
- Stock Market
- Equities
- 301239 Stock
- Financials Chengdu Bright Eye Hospital Co., Ltd.
